Press Releases

Lateral Flow Assays Market to Reach US$ 10.51 Bn by 2030

Share This Article

The global Lateral Flow Assays market is expected to grow at a CAGR of around 6.9% over the forecast period 2021 to 2030 and expected to reach the market value of around US$ 10.51 billion by 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38417

Growth Factors

 Major drivers of the market include an increase in the prevalence of infectious diseases, a rise in government initiatives to curb infectious and chronic diseases, a rise in demand for point of care testing, and strategic mergers & acquisitions among others.

Continuous strategic initiatives by leading and emerging players to develop and launch advanced products are anticipated to significantly support the market growth. For instance, in January 2021, U.K.-based Sensyne Health launched MagnifEye, a novel smartphone app that utilizes deep machine learning AI to automate the accurate reading of lateral flow diagnostic tests.

Report Coverage

Report Scope Details
Market Size US$ 10.51 Billion by 2030
Growth Rate CAGR of 6.9% From 2021 to 2030
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Product, Application, Technique, End-use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Abbott Laboratories; Thermo Fisher Scientific, Inc.; F. Hoffmann-La Roche AG; Bio-rad Laboratories, Inc.; Biomérieux SA; Quidel Corporation; Hologic, Inc.; Perkinelmer, Inc.; Merck KGAA; Becton, Dickinson and Company; Siemens Healthineers; Danaher Corporation; Qiagen N.V.

Report Highlights

 The kits and reagents segment accounted for the largest share of over 75.0% in 2020. The launch of new kits by major players is anticipated to boost the market growth during the forecast period. For instance, in February 2020, Shenzen Bioeasy Biotechnology announced that the company received CE marking for its COVID-19 LFA immunoassay kits.

the clinical testing segment accounted for the largest share of over 65.0% owing to the increased incidence of infectious diseases, including the outbreak of COVID-19. Lateral flow-based tests are widely used in physicians’ offices, hospitals, and clinical laboratories for the quantitative and qualitative detection of specific antibodies, products of gene amplification, and antigens. Lateral flow assay testing facilitates disease testing due to the ease of use and portability.

The drug development and quality testing segment is anticipated to register the fastest CAGR during the forecast period owing to the increase in the use of lateral flow assays for therapeutic drug monitoring. Complementary and companion lateral flow immunoassays are used across various less-regulated and regulated industries for the rapid production of fully and semi-quantitative results.

Sandwich assays held the largest share of over 55.0% in 2020 owing to their accuracy, affordability, and ease of use. In this technique, a positive test is mostly represented by a colored line at the test line position. The test can also be used in any low-resource healthcare or field setting and does not require training. The growing number of research activities undertaken by various research institutes is expected to boost market growth.

The hospitals and clinics segment held the largest share of over 45.0% in 2020. Hospitals and clinics are primary care settings for the diagnosis and treatment of medical conditions. The majority of the population relies on these long-term facilities for the diagnosis, treatment, and management of diseases. Constant changes in the healthcare industry have led to an increase in the need for hospitals with enhanced diagnostic services.

North America dominated the market with a share of more than 45.0% in 2020. This can be attributed to the easy availability and the high affordability of technologically advanced lateral flow assays. In addition, the high incidence of respiratory infections, such as COVID-19, influenza, and RSV, is boosting the demand for detection and treatment in the region.

Europe accounted for the second-largest market share in 2020.  A rise in the prevalence of respiratory diseases and the growing investments for the development of advanced diagnostics solutions are expected to drive the market in this region.

Key Players

  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche AG
  • Bio-rad Laboratories, Inc.
  • Biomérieux SA
  • Quidel Corporation
  • Hologic, Inc.
  • Perkinelmer, Inc.
  • Merck KGAA
  • Becton, Dickinson and Company
  • Siemens Healthineers
  • Danaher Corporation
  • Qiagen N.V.

Market Segmentation

  • Product OutlookKits & Reagents
    • Lateral Flow Readers
      • Digital/Mobile Readers
      • Benchtop Readers
  • Application Outlook
    • Clinical Testing
      • Infectious Diseases Testing
        • Mosquito Borne Disease Testing
        • Influenza Testing
        • Sexually Transmitted Infection Testing
          • HIV Testing
          • HPV Testing
          • Chlamydia Testing
          • Gonorrhea Testing
          • Syphilis Testing
          • Others
        • Hepatitis
        • Tuberculosis
        • Others
      •  Cardiac Marker Testing
        • Troponin I and T Testing
        • CK-MB Testing
        • BNP and NT-proBNP Testing
        • Myoglobin Testing
        • D-Dimer Testing
        • Others
      • Pregnancy & Fertility Testing
        • Pregnancy Testing
        • Fertility Testing
      • Cholesterol Testing/Lipid Profile Testing
      • Drugs of Abuse Testing
      • Others
    • Veterinary Diagnostics
    • Food safety & Environment Testing
    • Drug Development & Quality Testing
  • Technique Outlook
    • Sandwich Assays
    • Competitive Assays
    • Multiplex Detection Assays
  • End-use Outlook
    • Hospitals & Clinics
    • Diagnostic Laboratories
    • Home Care
    • Pharmaceutical & Biotechnology Companies
    • Others
  • Regional Outlook
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
      • Russia
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Australia
      • Singapore
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38417

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Lateral Flow Assays Market, By Product

7.1.  Lateral Flow Assays Market, by Product, 2020-2030

7.1.1.    Kits & Reagents

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Lateral Flow Readers

7.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Lateral Flow Assays Market, By Application

8.1.  Lateral Flow Assays Market, by Application, 2020-2030

8.1.1.    Clinical Testing

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Veterinary Diagnostics

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Food safety & Environment Testing

8.1.3.1.        Market Revenue and Forecast (2016-2030)

8.1.4.    Drug Development & Quality Testing

8.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Lateral Flow Assays Market, By Technique

9.1.  Lateral Flow Assays Market, by Technique, 2020-2030

9.1.1.    Sandwich Assays

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Competitive Assays

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Multiplex Detection Assays

9.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Lateral Flow Assays Market, By End-use

10.1.        Lateral Flow Assays Market, by End-use, 2020-2030

10.1.1.  Hospitals & Clinics

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Diagnostic Laboratories

10.1.2.1.      Market Revenue and Forecast (2016-2030)

10.1.3.  Home Care

10.1.3.1.      Market Revenue and Forecast (2016-2030)

10.1.4.  Pharmaceutical & Biotechnology Companies

10.1.4.1.      Market Revenue and Forecast (2016-2030)

10.1.5.  Others

10.1.5.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Lateral Flow Assays Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Product (2016-2030)

11.1.2.  Market Revenue and Forecast, by Application (2016-2030)

11.1.3.  Market Revenue and Forecast, by Technique (2016-2030)

11.1.4.  Market Revenue and Forecast, by End-use (2016-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.1.5.2.      Market Revenue and Forecast, by Application (2016-2030)

11.1.5.3.      Market Revenue and Forecast, by Technique (2016-2030)

11.1.5.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.1.6.2.      Market Revenue and Forecast, by Application (2016-2030)

11.1.6.3.      Market Revenue and Forecast, by Technique (2016-2030)

11.1.6.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Product (2016-2030)

11.2.2.  Market Revenue and Forecast, by Application (2016-2030)

11.2.3.  Market Revenue and Forecast, by Technique (2016-2030)

11.2.4.  Market Revenue and Forecast, by End-use (2016-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.5.2.      Market Revenue and Forecast, by Application (2016-2030)

11.2.5.3.      Market Revenue and Forecast, by Technique (2016-2030)

11.2.5.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.6.2.      Market Revenue and Forecast, by Application (2016-2030)

11.2.6.3.      Market Revenue and Forecast, by Technique (2016-2030)

11.2.6.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.7.2.      Market Revenue and Forecast, by Application (2016-2030)

11.2.7.3.      Market Revenue and Forecast, by Technique (2016-2030)

11.2.7.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.8.2.      Market Revenue and Forecast, by Application (2016-2030)

11.2.8.3.      Market Revenue and Forecast, by Technique (2016-2030)

11.2.8.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Product (2016-2030)

11.3.2.  Market Revenue and Forecast, by Application (2016-2030)

11.3.3.  Market Revenue and Forecast, by Technique (2016-2030)

11.3.4.  Market Revenue and Forecast, by End-use (2016-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.5.2.      Market Revenue and Forecast, by Application (2016-2030)

11.3.5.3.      Market Revenue and Forecast, by Technique (2016-2030)

11.3.5.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.6.2.      Market Revenue and Forecast, by Application (2016-2030)

11.3.6.3.      Market Revenue and Forecast, by Technique (2016-2030)

11.3.6.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.7.2.      Market Revenue and Forecast, by Application (2016-2030)

11.3.7.3.      Market Revenue and Forecast, by Technique (2016-2030)

11.3.7.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.8.2.      Market Revenue and Forecast, by Application (2016-2030)

11.3.8.3.      Market Revenue and Forecast, by Technique (2016-2030)

11.3.8.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Product (2016-2030)

11.4.2.  Market Revenue and Forecast, by Application (2016-2030)

11.4.3.  Market Revenue and Forecast, by Technique (2016-2030)

11.4.4.  Market Revenue and Forecast, by End-use (2016-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.5.2.      Market Revenue and Forecast, by Application (2016-2030)

11.4.5.3.      Market Revenue and Forecast, by Technique (2016-2030)

11.4.5.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.6.2.      Market Revenue and Forecast, by Application (2016-2030)

11.4.6.3.      Market Revenue and Forecast, by Technique (2016-2030)

11.4.6.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.7.2.      Market Revenue and Forecast, by Application (2016-2030)

11.4.7.3.      Market Revenue and Forecast, by Technique (2016-2030)

11.4.7.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.8.2.      Market Revenue and Forecast, by Application (2016-2030)

11.4.8.3.      Market Revenue and Forecast, by Technique (2016-2030)

11.4.8.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Product (2016-2030)

11.5.2.  Market Revenue and Forecast, by Application (2016-2030)

11.5.3.  Market Revenue and Forecast, by Technique (2016-2030)

11.5.4.  Market Revenue and Forecast, by End-use (2016-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.5.5.2.      Market Revenue and Forecast, by Application (2016-2030)

11.5.5.3.      Market Revenue and Forecast, by Technique (2016-2030)

11.5.5.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.5.6.2.      Market Revenue and Forecast, by Application (2016-2030)

11.5.6.3.      Market Revenue and Forecast, by Technique (2016-2030)

11.5.6.4.      Market Revenue and Forecast, by End-use (2016-2030)

Chapter 12.  Company Profiles

12.1.              Abbott Laboratories

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Thermo Fisher Scientific, Inc.

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              F. Hoffmann-La Roche AG

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Bio-rad Laboratories, Inc.

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Biomérieux SA

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Quidel Corporation

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Hologic, Inc.

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Perkinelmer, Inc.

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Merck KGAA

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Becton, Dickinson and Company

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

12.11.           Siemens Healthineers

12.11.1.               Company Overview

12.11.2.               Product Offerings

12.11.3.               Financial Performance

12.11.4.               Recent Initiatives

12.12.           Danaher Corporation

12.12.1.               Company Overview

12.12.2.               Product Offerings

12.12.3.               Financial Performance

12.12.4.               Recent Initiatives

12.13.           Qiagen N.V.

12.13.1.               Company Overview

12.13.2.               Product Offerings

12.13.3.               Financial Performance

12.13.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38417

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com

Related Articles

Back to top button